Background and purpose: 15% of cerebral venous thrombosis (CVT) patients have poor
outcomes despite anticoagulation. Uncontrolled studies suggest that endovascular …

Objective: To investigate recanalisation in the first 12 months after cerebral venous
thrombosis. Methods: 33 consecutive patients presenting with cerebral venous thrombosis …

Background: Little information is available on the long‐term clinical outcome of cerebral vein
thrombosis (CVT). Objectives and methods: In an international, retrospective cohort study …

Dural sinus or cerebral venous thrombosis (CVT) is a frequently unrecognized cause of
stroke affecting predominantly young women. Typical clinical signs include headache, visual …

Cerebral venous thrombosis (CVT) was formerly considered a rare disorder, associated with
an unfavorable outcome. More recent data based on modern imaging techniques, however …

Objective Cerebral venous sinus thrombosis (CVST) is increasingly being recognized in the
setting of traumatic brain injury (TBI), but its effect on TBI patients and its management …

After Ribes'1 initial description in 1825 of a patient with cerebral venous thrombosis (CVT),
this disorder was universally considered to be fatal, the diagnosis being made at …

Object Although initially described in the 19th century, cerebral venous sinus thrombosis
(CVST) remains a diagnostic and therapeutic dilemma. It has an unpredictable course, and …

Cerebral venous thrombosis (CVT) is a rare type of cerebrovascular disease that can occur
at any age, including in neonates, and it accounts for 0· 5% of all stroke. The widespread …

Cerebral vein thrombosis (CVT) is a rare presentation of venous thromboembolism. Prompt
and accurate diagnosis is essential as delayed recognition and treatment may lead to …